Can HPV testing replace the pap smear?
- 14 September 2010
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1205 (1) , 51-56
Abstract
The most compelling question in evaluating the possible replacement of the conventional Papanicolaou smear from a high‐risk HPV testing method is the balance between specificity and sensitivity for detection of cervical intraepithelial neoplasia grade ≥CIN 2 (CIN 2+). Multiple studies have shown that HPV testing has higher sensitivity than cytology for the detection of high‐grade CIN. Positivity increases the test cut‐off for HPV and may reduce false positive results without significantly compromising the sensitivity, potentially alleviating the concern of low specificity. Overall, available evidence convincingly shows that HPV testing is superior to traditional screening for the detection of high‐grade cervical lesions, and efforts are focused on improving its sensitivity, either by increasing its cut‐off for positivity or by selecting those subgroups where HPV testing is expected to have higher positive predictive value for cervical disease, or by seeking to optimize triage tests after a positive HPV result.Keywords
This publication has 33 references indexed in Scilit:
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and olderInternational Journal of Cancer, 2008
- Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in IndiaBritish Journal of Cancer, 2008
- Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening TestJNCI: Journal of the National Cancer Institute, 2008
- Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 VaccinationJNCI: Journal of the National Cancer Institute, 2008
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007
- High-risk HPV type-specific clearance rates in cervical screeningBritish Journal of Cancer, 2007
- Clinical utility of HPV–DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidenceGynecologic Oncology, 2005
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI: Journal of the National Cancer Institute, 2005
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003